ACET - Aceto Corporation Summary, Stock Quote and News | Benzinga

Market Overview

2.170 -0.04 (-1.81%)

Data as of Oct 15, 2018

Prev. Close 2.21
Price Open 2.21
Volume 119,004
Day's Range 2.13 - 2.23
52 Wk Range 2.1 - 11.98
50 Day Moving Avg. 2.95
PE Ratio 0
Shares Outstanding 30.79M
Market Cap 67.12M

Trade ACET stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results Shanthi RexalineFri, 28 Sep 2018 08:10:46 -0400
Aceto Q4 EPS $(0.48) Misses $(0.04) Estimate, Sales $168.877M Miss $168.95M Estimate Benzinga NewsdeskFri, 28 Sep 2018 06:59:59 -0400
41 Biggest Movers From Yesterday Lisa LevinThu, 27 Sep 2018 05:01:51 -0400
30 Stocks Moving In Wednesday's Mid-Day Session Lisa LevinWed, 26 Sep 2018 12:32:40 -0400
Mid-Day Market Update: Electromed Surges After Q4 Results; Digital Ally Shares Slide Lisa LevinWed, 26 Sep 2018 12:05:08 -0400
Mid-Morning Market Update: Markets Edge Higher; CarMax Tops Q2 Expectations Lisa LevinWed, 26 Sep 2018 10:13:48 -0400
The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial Shanthi RexalineWed, 26 Sep 2018 08:25:04 -0400
UPDATE: Garrett Motion To Replace Aceto In S&P SmallCap 600 Benzinga NewsdeskTue, 25 Sep 2018 17:22:26 -0400
Stocks That Will Be Trading Ex Dividend Fri., Sep. 21, 2018 Benzinga NewsdeskThu, 20 Sep 2018 06:34:19 -0400
Earnings Scheduled For September 12, 2018 Lisa LevinWed, 12 Sep 2018 04:02:26 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Aceto Corporation (ACET) and Encourages ACET Investors to Contact the Firm Globe Newswire6 days ago
Aceto Investigation: Bernstein Liebhard LLP Announces Investigation Of Aceto Corporation - ACET PRNewswireSep 28, 2018
ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results Globe NewswireSep 28, 2018
Rollins Set to Join S&P 500; Inogen to Join S&P MidCap 400; Vanda Pharmaceuticals and Garrett Motion to Join S&P SmallCap 600 PRNewswireSep 25, 2018
Lawsuit for Investors in NASDAQ: ACET shares against Aceto Corporation announced by Shareholders Foundation Globe NewswireSep 17, 2018
ACETO Announces Credit Agreement Amendment Globe NewswireSep 12, 2018
ACETO Corporation Schedules Fourth Quarter & Fiscal 2018 Financial Results News Release and Conference Call Globe NewswireAug 30, 2018
Research Report Identifies Aceto, Bridgepoint Education, OFG, Heritage Financial, PCM, and First Cash with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement Globe NewswireAug 03, 2018
ACETO Subsidiary Acetris Health Receives Favorable Ruling Regarding Certain Government Contracts Globe NewswireJul 16, 2018
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aceto Corporation (ACET) and Lead Plaintiff Deadline – June 25, 2018 Globe NewswireJun 25, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

FDA issues new guidance for developers of complex generics Seeking Alpha6 days ago
Generics in the green following proposed favorable guidance from FDA Seeking AlphaOct 02, 2018
Aceto Corporation (ACET) CEO William Kennally on Q4 2018 Results - Earnings Call Transcript Seeking AlphaSep 28, 2018
Aceto reports lower Q4 sales and margin pressures; shares down ~7% Seeking AlphaSep 28, 2018
Aceto Corporation 2018 Q4 - Results - Earnings Call Slides Seeking AlphaSep 28, 2018
Aceto misses by $0.44, revenue in-line Seeking AlphaSep 28, 2018
After Hours Gainers / Losers (09/27/2018) Seeking AlphaSep 27, 2018
Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/26/2018) Seeking AlphaSep 26, 2018
Midday Gainers / Losers (09/26/2018) Seeking AlphaSep 26, 2018
Vanda Pharma gains, Aceto drops amid S&P index changes Seeking AlphaSep 25, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Powered by StockSnips

34.76% Negative

Earnings View Earnings

Q4 2018	EST	Actual	Surprise
EPS:	-0.04	-0.48	-0.44
Rev:	168.95M	168.88M	-73.00K

Q1 2019	EST	Actual	Surprise
EPS:	Expected 2018-11-01
Rev:	Expected 2018-11-01

Company Profile

Read More

Brokerage Center

Compare All Online Brokerages